Stay updated on Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial

Sign up to get notified when there's something new on the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0 and removed Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-19T23:52:23.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.2 to v3.4.3. It appears to be a backend/UI update with no visible changes to study details or eligibility.
    Difference
    0.1%
    Check dated 2026-03-12T20:20:05.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The change consists of Revision: v3.4.2 replacing v3.4.1, which appears to be a metadata/version update without altering study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-12T01:46:14.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.0 to v3.4.1.
    Difference
    0.1%
    Check dated 2026-02-04T23:46:16.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Added a glossary section; updated capitalization of labels such as 'Last Update Submitted that Met QC Criteria' and the FEAR Act notice, and updated the site revision to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T21:48:36.000Z thumbnail image
  9. Check
    93 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T04:27:17.000Z thumbnail image

Stay in the know with updates to Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nab-Sirolimus in Liver-Impaired Cancer Patients Clinical Trial page.